GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Opthea Ltd (NAS:OPT) » Definitions » 3-Year Revenue Growth Rate

Opthea (Opthea) 3-Year Revenue Growth Rate : 0.00% (As of Dec. 2023)


View and export this data going back to 2011. Start your Free Trial

What is Opthea 3-Year Revenue Growth Rate?

Opthea's Revenue per Share for the six months ended in Dec. 2023 was $0.00.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.


Competitive Comparison of Opthea's 3-Year Revenue Growth Rate

For the Biotechnology subindustry, Opthea's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Opthea's 3-Year Revenue Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Opthea's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Opthea's 3-Year Revenue Growth Rate falls into.



Opthea 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.


Opthea  (NAS:OPT) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.


Opthea 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Opthea's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Opthea (Opthea) Business Description

Industry
Traded in Other Exchanges
Address
650 Chapel Street, Level 4, Suite 0403, South Yarra, VIC, AUS, 3141
Opthea Ltd operates in one industry being the medical technology and healthcare. It is focused primarily on developing biological therapeutics for eye diseases. The company is developing a novel biologic therapy, OPT-302, for the treatment of eye diseases. Its products are based on the intellectual property portfolio covering Vascular Endothelial Growth Factors C and D and R3 targets. Opthea's development activities are based on an intellectual property portfolio covering key targets Vascular Endothelial Growth Factors VEGF-C, VEGF-D and VEGF Receptor-3 for the treatment of diseases associated with blood and lymphatic vessel growth, as well as vascular leakage.

Opthea (Opthea) Headlines

From GuruFocus

Opthea to Present at Jefferies London Healthcare Conference

By Value_Insider Value_Insider 11-10-2022

Opthea To Present at Sequire Biotechnology Conference

By Stock market mentor Stock market mentor 01-30-2023

Top 5 4th Quarter Trades of Regal Partners Ltd

By GuruFocus Research GuruFocus Editor 02-20-2023

Opthea To Present at the JMP Securities Life Sciences Conference

By sperokesalga sperokesalga 05-08-2023

Opthea To Present at SVB Leerink Global Biopharma Conference

By Stock market mentor Stock market mentor 02-06-2023